A once-daily oral version of Wegovy begins selling in the UK at high-street and online pharmacies, with dispensing starting from Monday. The pill is made by Novo Nordisk and is presented as an oral alternative to the company’s Wegovy weight-loss injection. Multiple outlets report that the tablet uses semaglutide, the same active GLP-1 ingredient found in the injectable treatment, and trials indicate it is similarly effective. Sources also note that demand is expected to rise as the product becomes available more widely through retail pharmacy supply chains. While pharmacies can begin dispensing the medication, the Guardian reports it is not yet available through the NHS. Other coverage focuses on the start of sales and highlights that pharmacies are launching the treatment with published UK pricing lists. Overall, the launch marks the first time this weight-loss injection option in pill form is available to patients via UK pharmacies, with access to NHS prescribing not yet confirmed.